1025 related articles for article (PubMed ID: 23928066)
1. [Antipsychotic-drug-induced hyperprolactinemia: physiopathology, clinical features and guidance].
Besnard I; Auclair V; Callery G; Gabriel-Bordenave C; Roberge C
Encephale; 2014 Feb; 40(1):86-94. PubMed ID: 23928066
[TBL] [Abstract][Full Text] [Related]
2. Antipsychotic-induced hyperprolactinaemia: mechanisms, clinical features and management.
Haddad PM; Wieck A
Drugs; 2004; 64(20):2291-314. PubMed ID: 15456328
[TBL] [Abstract][Full Text] [Related]
3. [Hyperprolactinemia in mentally ill patients].
Carvalho MM; Góis C
Acta Med Port; 2011; 24(6):1005-12. PubMed ID: 22713195
[TBL] [Abstract][Full Text] [Related]
4. [Antipsychotics and hyperpolactinaemia: pathophysiology, clinical relevance, diagnosis and therapy].
Riecher-Rössler A; Schmid C; Bleuer S; Birkhäuser M
Neuropsychiatr; 2009; 23(2):71-83. PubMed ID: 19573500
[TBL] [Abstract][Full Text] [Related]
5. Antipsychotic-induced hyperprolactinaemia, hypogonadism and osteoporosis in the treatment of schizophrenia.
O'Keane V
J Psychopharmacol; 2008 Mar; 22(2 Suppl):70-5. PubMed ID: 18477623
[TBL] [Abstract][Full Text] [Related]
6. [Atypical antipsychotics and sexual dysfunction: five case-reports associated with risperidone].
Haefliger T; Bonsack C
Encephale; 2006; 32(1 Pt 1):97-105. PubMed ID: 16633296
[TBL] [Abstract][Full Text] [Related]
7. Time course of the changes in antipsychotic-induced hyperprolactinemia following the switch to aripiprazole.
Lu ML; Shen WW; Chen CH
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Dec; 32(8):1978-81. PubMed ID: 18848860
[TBL] [Abstract][Full Text] [Related]
8. Antipsychotic-induced hyperprolactinemia.
Bostwick JR; Guthrie SK; Ellingrod VL
Pharmacotherapy; 2009 Jan; 29(1):64-73. PubMed ID: 19113797
[TBL] [Abstract][Full Text] [Related]
9. Antipsychotic-induced hyperprolactinemia and sexual dysfunction.
Compton MT; Miller AH
Psychopharmacol Bull; 2002; 36(1):143-64. PubMed ID: 12397853
[TBL] [Abstract][Full Text] [Related]
10. The effects of antipsychotic-induced hyperprolactinaemia on the hypothalamic-pituitary-gonadal axis.
Smith S; Wheeler MJ; Murray R; O'Keane V
J Clin Psychopharmacol; 2002 Apr; 22(2):109-14. PubMed ID: 11910254
[TBL] [Abstract][Full Text] [Related]
11. Atypical antipsychotics: mechanism of action.
Seeman P
Can J Psychiatry; 2002 Feb; 47(1):27-38. PubMed ID: 11873706
[TBL] [Abstract][Full Text] [Related]
12. Positron emission tomography measurement of dopamine D₂ receptor occupancy in the pituitary and cerebral cortex: relation to antipsychotic-induced hyperprolactinemia.
Arakawa R; Okumura M; Ito H; Takano A; Takahashi H; Takano H; Maeda J; Okubo Y; Suhara T
J Clin Psychiatry; 2010 Sep; 71(9):1131-7. PubMed ID: 20361897
[TBL] [Abstract][Full Text] [Related]
13. Antipsychotic-induced hyperprolactinemia inhibits the hypothalamo-pituitary-gonadal axis and reduces bone mineral density in male patients with schizophrenia.
Kishimoto T; Watanabe K; Shimada N; Makita K; Yagi G; Kashima H
J Clin Psychiatry; 2008 Mar; 69(3):385-91. PubMed ID: 18278991
[TBL] [Abstract][Full Text] [Related]
14. Management of psychotropic-induced hyperprolactinemia.
Marken PA; Haykal RF; Fisher JN
Clin Pharm; 1992 Oct; 11(10):851-6. PubMed ID: 1341991
[TBL] [Abstract][Full Text] [Related]
15. Psychotropic-induced hyperprolactinemia: a clinical review.
Ajmal A; Joffe H; Nachtigall LB
Psychosomatics; 2014; 55(1):29-36. PubMed ID: 24140188
[TBL] [Abstract][Full Text] [Related]
16. Antipsychotic-induced hyperprolactinaemia.
Inder WJ; Castle D
Aust N Z J Psychiatry; 2011 Oct; 45(10):830-7. PubMed ID: 21714721
[TBL] [Abstract][Full Text] [Related]
17. Prolactin and antipsychotic medications: mechanism of action.
Petty RG
Schizophr Res; 1999 Mar; 35 Suppl():S67-73. PubMed ID: 10190227
[TBL] [Abstract][Full Text] [Related]
18. The effects of novel and newly approved antipsychotics on serum prolactin levels: a comprehensive review.
Peuskens J; Pani L; Detraux J; De Hert M
CNS Drugs; 2014 May; 28(5):421-53. PubMed ID: 24677189
[TBL] [Abstract][Full Text] [Related]
19. Medical causes and consequences of hyperprolactinaemia. A context for psychiatrists.
Holt RI
J Psychopharmacol; 2008 Mar; 22(2 Suppl):28-37. PubMed ID: 18477618
[TBL] [Abstract][Full Text] [Related]
20. Antipsychotic medication in children and adolescents: a descriptive review of the effects on prolactin level and associated side effects.
Roke Y; van Harten PN; Boot AM; Buitelaar JK
J Child Adolesc Psychopharmacol; 2009 Aug; 19(4):403-14. PubMed ID: 19702492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]